|
ISPOR 11th Annual European Congress Scientific Awards Recipients
Stephen Priori, Director, ISPOR Publications
The ISPOR Best Research Podium and Poster Presentation Awards were established in 1998 to recognize the scientific merit of podium and poster presentations
of the ISPOR Annual International Meetings, Annual European Congresses, and Asia-Pacific Conferences. At this year's European Congress, the ISPOR Awards
Committee evaluated approximately 76 podium presentations and over 900 poster presentations.
| SCIENTIFIC AWARD RECIPIENTS |
BEST CONTRIBUTED PODIUM AWARDS PRESENTATIONS
HT3 A COMPARISON OF REASONS FOR RECOMMENDATION AND REJECTION IN
FOUR HEALTH TECHNOLOGY APPRAISAL SYSTEMS: NICE, SMC, CADTH AND PBAC
Cann K, Karia R, Plested M, Samuels E, Zwaferink H, Heron Evidence Development
Ltd, Letchworth Garden City, UK
MO2 INCORPORATING CALIBRATED MODEL PARAMETERS INTO SENSITIVITY
ANALYSES: DETERMINISTIC AND PROBABILISTIC APPROACHES
Taylor DC1, Kruzikas D2, Pawar V3, Gilmore K1, Naik S1, Weinstein MC4, 1i3 Innovus,
Medford, MA, USA, 2GlaxoSmithKline, Philadelphia, PA, USA, 3Innovus Research, Inc,
Medford, MA, USA, 4i3 Innovus Research Inc., Harvard School of Public Health, Harvard
Medical School, Boston, MA, USA
MS3 POPULATION HEALTH-STATE UTILITIES FOR FIBROMYALGIA IN THE UK
Hauber AB1, McCrink L2, Beard S2, Garcia-Cebrian A3, Maas G4, Das Gupta R5, Le TK6,
1RTI Health Solutions, Research Triangle Park, NC, USA, 2RTI Health Solutions,
Manchester, UK, 3Eli Lilly and Company Limited, Basingstoke, UK, 4Boehringer
Ingelheim GmbH, Ingelheim, Germany, 5Boehringer Ingelheim, Bracknell, Berkshire, UK,
6Eli Lilly and Company, Indianapolis, IN, USA |
|
BEST NEW INVESTIGATOR POSTER AWARDS PRESENTATIONS
PCN6 MODELING LUNG AND BREAST CANCER INCIDENCE IN SPAIN: A ZERO
INFLATED NEGATIVE BINOMIAL REGRESSION APPROACH
Villa G, Cuervo J, Rebollo P, BAP Health Outcomes Research, Oviedo, Asturias, Spain
PCN21 COST-EFFECTIVENESS OF LAPATINIB PLUS CAPECITABINE FOR WOMEN
WITH HER2+ METASTATIC BREAST CANCER PREVIOUSLY TREATED WITH TRATSTUZUMAB
IN FINLAND
Färkkilä N1, Torvinen S1, Bergius S1, Delea T2, Sofrygin O2, Walker M3, 1GlaxoSmithKline
Oy, Espoo, Finland, 2Policy Analysis Inc. (PAI), Brookline, MA, USA, 3GlaxoSmithKline,
London, UK
PCN67 COST UTILITY ANALYSIS OF ALEMTUZUMAB COMPARED TO CHLORAMBUCIL
IN UNTREATED PATIENTS WITH HIGH-RISK (17P-) CHRONIC LYMPHOCYTIC
LEUKEMIA IN THE UNITED KINGDOM
Lloyd AC1, Valderrama A2, Ferguson J3, Gilmour L3, Ravndal F1, 1IMS, London, UK,
2Bayer Healthcare Pharmaceuticals Inc, Pine Brook, NJ, USA, 3Bayer Healthcare
Pharmaceuticals Inc, Newbury, Berkshire, UK |
| |
|
|
BEST NEW INVESTIGATOR PODIUM AWARDS PRESENTATIONS
AR3 TO INVESTIGATE THE BENEFIT OF ANTI-TNF THERAPY ON PHYSICAL AND
MENTAL FUNCTIONING VIA THE SHORT FORM-36 QUALITY OF LIFE QUESTIONNAIRE
IN PATIENTS WITH RHEUMATOID ARTHRITIS
Adams R1, Ng CT2, Gibbs A3, Bresnihan B4, Veale D5, Tilson L1, FitzGerald O5, Barry M1,
1National Centre for Pharmacoeconomics, Dublin, Ireland, 2St.Vincents University,
Dublin, Ireland, 3Galway Clinic, Galway, Ireland, 4St. Vincents University Hospital,
Dublin, Ireland, 5St.Vincents University Hospital, Dublin, Ireland
CN6 COST-EFFECTIVENESS OF A HUMAN PAPILLOMAVIRUS VACCINE IN
REDUCING THE RISK OF CERVICAL CANCER IN IRELAND USING A TRANSMISSION
DYNAMIC MODEL
Usher C1, Tilson L1, Olsen J2, Rudbeck Jepsen M3, Walsh C4, Barry M1, 1National Centre
for Pharmacoeconomics, Dublin, Ireland, 2University of Southern Denmark, Odense,
Denmark, 3Statens Serum Institut, DK-2300 Copenhagen S, Denmark, 4Trinity College
Dublin, Dublin, Ireland
MH2 THE SUSTAINED DIAGNOSIS OF ATTENTION-DEFICIT HYPERACTIVITY
DISORDER FROM CHILDHOOD TO ADULTHOOD: A MEDICAID STUDY
Chen H, Sudharshan L, University of Houston, Houston, TX, USA |
|
BEST STUDENT POSTER AWARDS PRESENTATIONS
PDB65 A COMPARISON OF DIABETES KNOWLEDGE AMONG RESIDENTS IN
BANGKOK AND OTHER CENTRAL PROVINCES OF THAILAND
Pongmesa T1, Li SC2, Wee HL1, 1National University of Singapore, Singapore,
2University of Newcastle, Callaghan, Australia
PND3 ANTI-EPILEPTIC MEDICATION DRUG FORMULATION CHANGES AND THEIR
RELATIONSHIP TO OUTCOMES (AMBULANCE, EMERGENCY DEPARTMENT AND
INPATIENT EVENTS
Mann TA, Rascati KL, Richards KM, Johnsrud M, The University of Texas at Austin,
Austin, TX, USA
PSY62 A NATURAL EXPERIMENT TO ESTIMATE THE IMPACT OF A PREFERRED
DRUG LIST POLICY FOR LONG ACTING NARCOTIC ANALGESICS ON COSTS AND
UTILIZATION
Flannagin KR, Martin BC, University of Arkansas for Medical Sciences, Little Rock, AR,
USA |
| |
|
|
BEST STUDENT PODIUM AWARD PRESENTATION
MH7 PATIENT REPORTED OBJECTIVES AND PRIORITIES FOR THE TREATMENT
OF SCHIZOPHRENIA IN GERMANY: A MIXED METHODS APPROACH TO
CAPTURING THE PATIENT'S PERSPECTIVE
Kinter ET1, Rudolph I2, Schmeding A2, Bridges JF1, 1Johns Hopkins University,
Bloomberg School of Public Health, Baltimore, MD, USA, 2Janssen-Cilag GmbH,
Neuss, Germany |
|
ISPOR ANNUAL EUROPEAN CONGRESS RESEARCH AWARDS CHAIRS:
Podium: Uwe Siebert, MD, MPH, MSc, ScD, Professor of Public Health (UMIT),
Adjunct Professor of Health Policy and Management (Harvard School of Public Health);
Chair of Department of Public Health, Medical Decision Making and Health Technology;
University of Health Sciences, Medical Informatics and Technology; Hall/Innsbruck,
Austria
Poster: Evi Hatziandreou MD, DrPH, Director, Health and Healthcare, RAND Europe,
Cambridge, UK
A special thanks goes to all the judges, the ISPOR Annual European Congress
Research Awards Chairs as well as the ISPOR Awards Committee Chair who volunteered
their time and efforts in selecting the winners. |
| |
|
|
BEST CONTRIBUTED PAPER AWARDS POSTER PRESENTATIONS
PIN24 ECONOMIC AND CLINICAL IMPACT OF IMPLEMENTATION OF AN ACELLULAR
PERTUSSIS VACCINE IN CANADA
Iskedjian M1, Walker J1, De Serres G2, Einarson TR1, 1PharmIdeas Research and
Consulting Inc, Oakville, ON, Canada, 2Université Laval, Québec, QC, Canada
PMS47 USING HAQ TO ESTIMATE HUI3 AND EQ-5D UTILITY VALUES IN
SPANISH RHEUMATOID ARTHRITIS PATIENTS
Fernández I1, Varela C1, Layola M2, Ruiz MD3, Navarro F3, 1Roche Farma, Madrid, Spain,
2IMS Health, Barcelona, Spain, 3Hospital Universitario Virgen Macarena, Sevilla, Spain
PSY33 CLINICAL AND ECONOMIC OUTCOMES ASSOCIATED WITH BLOOD
TRANSFUSION DURING INPATIENT HOSPITALIZATION: AN ANALYSIS OF THE
2004 HEALTH CARE COST AND UTILIZATION PROJECT NATIONWIDE INPATIENT
SAMPLE DATABASE
Patel ST1, Anastassopoulos K1, Lerner J1, Ryan K1, Dodd SL2, Goss TF1, Morton J3,
1Covance Market Access Services, Gaithersburg, MD, USA, 2Ethicon, Inc, Silesia, MT,
USA, 3Stanford University School of Medicine, Stanford, CA, USA |
|
ISPOR JUDGES:
Christos Chouaid, Clark Paramore, Carole Coudray Omnes, John Bridges, Carl Asche,
Laura McCullagh, Denis Getsios, Brett Hauber, Michael Iskedjian, Gabriela Tannus, Ian
Johnson, Katy Slack, Matthew Treaney, Birgitta von Scheele, Lauren Lent, Donald
Bushnell, Karen Rascati, Rajesh Balkrishnan, Kristen Migliaccio, Robert Plisko,
Deborah Lubeck, Joice Valentim, Ljubica Besker, Hiltrud Liedgens, Mohammad
Addollahi, Kirsten Long, Adele Weston, Axel Muhlbacher, Bernard Selke, Sinisa Antolic,
Hsing Yi, Matthieu Cuche, Erwin De Cock, Lee Moore, Erna, Ribnicsek, Christel
Naujoks, Katalin Rapi, Tony Eti-ukwu, Tipaporn Pongmesa, Michael Minshall, Meir
Oren, Nikfar Sheloufeh, Jan Sabo, Beth O'Leary, Zahra Pourmoghaddas, Michael Ganz,
Barbara Poulsen-Nautrup, Victoria Brennan, Bradley Martin, Samuel Wagner, Elli
Vitsou, Mario Stegert, Siew Hwa Ong, Janneke Grutters, Anna Vavrovsky, Lynda
Doward, Hicham Benhaddi, Fleur Levrat, Anne Solesse, Patrick Mollon, Iwona
Skrekowska-Baran, Su-Fen Tsai, Chuong Ho, Ahmed Al-Ansi, James Palmer, Yajaira
Bastardo, Floortje VanNooten |
|